SUMMIT THERAPEUTICS INC (SMMT)
US86627T1088 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-1-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -614.93M | -78.78M | -88.60M | -52.70M | 9.90M | |||
| Depreciation Amortization | 198.00K | 1.26M | 1.35M | 1.55M | 1.77M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | -940.00K | |||
| Change In Working Capital | -2.37M | 8.62M | -70.00K | 620.00K | -54.87M | |||
| Interest Paid | 10.65M | 430.00K | 90.00K | N/A | N/A | |||
| Taxes Paid | 52.00K | N/A | 10.00K | -70.00K | 70.00K | |||
| Other non cash items | 540.34M | 27.32M | 14.74M | 2.42M | 9.03M | |||
| OPERATING CASH FLOW | -76.76M | -41.58M | -72.59M | -48.11M | -35.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -128.00K | -620.00K | -310.00K | -420.00K | -160.00K | |||
| Other Investing Activity | -587.65M | N/A | N/A | 0.00 | -170.00K | |||
| INVESTING CASH FLOW | -587.77M | -620.00K | -310.00K | -420.00K | -330.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -24.69M | 520.00M | 0.00 | N/A | N/A | |||
| Stock Issued/Repurchased | 111.82M | 100.40M | 78.09M | 50.60M | 46.22M | |||
| Other Financing Activity | -619.00K | -160.00K | -170.00K | -50.00K | -1.71M | |||
| FINANCING CASH FLOW | 86.51M | 620.24M | 77.92M | 50.55M | 44.51M | |||
| Exchange Rate Effect | 839.00K | -1.22M | 350.00K | 560.00K | -2.32M | |||
| CHANGE IN CASH | -577.18M | 576.82M | 5.37M | 2.58M | 6.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -76.76M | -41.58M | -72.59M | -48.11M | -35.11M | |||
| Capital Expenditure | -128.00K | -620.00K | -310.00K | -420.00K | -160.00K | |||
| FREE CASH FLOW | -76.89M | -42.20M | -72.90M | -48.53M | -35.27M | |||
All data in USD